Jacobs Levy Equity Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $636K | Sell |
92,470
-55,184
| -37% | -$380K | ﹤0.01% | 834 |
|
|
2025
Q1 | $425K | Buy |
+147,654
| New | +$425K | ﹤0.01% | 938 |
|
|
2024
Q4 | – | Sell |
-202,030
| Closed | -$721K | – | 981 |
|
|
2024
Q3 | $721K | Buy |
+202,030
| New | +$721K | ﹤0.01% | 783 |
|
|
2024
Q2 | – | Sell |
-20,472
| Closed | -$193K | – | 996 |
|
|
2024
Q1 | $193K | Sell |
20,472
-101,658
| -83% | -$960K | ﹤0.01% | 894 |
|
|
2023
Q4 | $824K | Sell |
122,130
-143,376
| -54% | -$968K | ﹤0.01% | 755 |
|
|
2023
Q3 | $1.18M | Buy |
+265,506
| New | +$1.18M | 0.01% | 646 |
|
|
2021
Q4 | – | Sell |
-7,487
| Closed | -$211K | – | 1009 |
|
|
2021
Q3 | $211K | Sell |
7,487
-6,302
| -46% | -$178K | ﹤0.01% | 981 |
|
|
2021
Q2 | $145K | Buy |
+13,789
| New | +$145K | ﹤0.01% | 1004 |
|
|
2021
Q1 | – | Sell |
-15,692
| Closed | -$184K | – | 1056 |
|
|
2020
Q4 | $184K | Sell |
15,692
-647
| -4% | -$7.59K | ﹤0.01% | 967 |
|
|
2020
Q3 | $130K | Sell |
16,339
-2,355
| -13% | -$18.7K | ﹤0.01% | 988 |
|
|
2020
Q2 | $342K | Buy |
18,694
+7,502
| +67% | +$137K | ﹤0.01% | 861 |
|
|
2020
Q1 | $134K | Buy |
+11,192
| New | +$134K | ﹤0.01% | 936 |
|